Log in to save to my catalogue

Polymorphisms of methylenetetrahydrofolate reductase and the risk of prostate cancer: a nested case–...

Polymorphisms of methylenetetrahydrofolate reductase and the risk of prostate cancer: a nested case–...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_DiVA_org_umu_15281

Polymorphisms of methylenetetrahydrofolate reductase and the risk of prostate cancer: a nested case–control study

About this item

Full title

Polymorphisms of methylenetetrahydrofolate reductase and the risk of prostate cancer: a nested case–control study

Publisher

England: Lippincott Williams & Wilkins

Journal title

European journal of cancer prevention, 2006-02, Vol.15 (1), p.46-50

Language

English

Formats

Publication information

Publisher

England: Lippincott Williams & Wilkins

More information

Scope and Contents

Contents

It has been proposed that folate and polymorphisms of the enzyme methylenetetrahydrofolate reductase (MTHFR), which regulates influx of folate from DNA synthesis and repair to methylation reactions, are involved in the aetiology of cancer. To relate the MTHFR 677C→T and 1298A→C polymorphisms to the risk of prostate cancer, taking into consideration...

Alternative Titles

Full title

Polymorphisms of methylenetetrahydrofolate reductase and the risk of prostate cancer: a nested case–control study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_swepub_primary_oai_DiVA_org_umu_15281

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_DiVA_org_umu_15281

Other Identifiers

ISSN

0959-8278,1473-5709

E-ISSN

1473-5709

DOI

10.1097/01.cej.0000186640.19872.4d

How to access this item